ALX Oncology Holdings Inc. (“ALX Oncology,” Nasdaq: ALXO), a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat cancer and extend patients’ lives, announced ...
Orum Therapeutics ("Orum" or the "Company") (KRX: 475830), a biotechnology company pioneering the field of degrader-antibody conjugates (DACs), today announced the presentation of new preclinical data ...
TheFly reported on April 8 that Morgan Stanley reduced its price target on BCYC to $12 from $13 while maintaining an Equal ...
This week on the Cyclist Magazine Podcast, James and Will chat to George Hincapie, the super-est of domestiques, double 'ard ...
In this Healio video, Alissa J. Cooper, MD, a thoracic oncologist at Dana-Farber Cancer Institute, discusses results from the OptiTROP-Lung03 study, which were presented at European Lung Cancer ...
Lisa Taylor Ash joins Board of Directors, strengthening operational, regulatory and commercial expertise DUBLIN and LONDON, ...
Waters Corporation (NYSE: WAT) today announced the launch of the Waters omniDAWN™ Multi-Angle Light Scattering (M ...
GSK ( GSK) is preparing a high-stakes push into oncology, lining up five late-stage trials at once for a promising cancer ...
Christoph has played a pivotal role in shaping the Company's strategic transformation since his appointment as Chief Business Officer in January 2025 C ompany Founder Jacques Lemmens, PhD, remains as ...
A highway sign indicating the exit for Cesar E. Chavez Boulevard hangs over I-35 in San Antonio. Despite a city survey ...
After entering 2026 hungry for deals, Gilead Sciences has wasted no time eating its fill. | After entering 2026 hungry for ...
Valitor, a biotechnology company engineering a new generation of ophthalmic medicines, today announced the company will present new preclinical data highlighting the potential of VLTR-559, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results